237 related articles for article (PubMed ID: 26613391)
1. Pitting new treatments for chronic lymphocytic leukemia against old ones: how do they fare?
Shvidel L; Berrebi A
Expert Rev Hematol; 2016 Mar; 9(3):245-54. PubMed ID: 26613391
[TBL] [Abstract][Full Text] [Related]
2. [Chronic lymphatic leukemia].
Bergmann M; Wendtner CM
Dtsch Med Wochenschr; 2015 Apr; 140(7):479-82. PubMed ID: 25826029
[TBL] [Abstract][Full Text] [Related]
3. Prognostic markers and standard management of chronic lymphocytic leukemia.
Stilgenbauer S
Hematology Am Soc Hematol Educ Program; 2015; 2015():368-77. PubMed ID: 26637745
[TBL] [Abstract][Full Text] [Related]
4. Chronic lymphocytic leukemia: 2015 Update on diagnosis, risk stratification, and treatment.
Hallek M
Am J Hematol; 2015 May; 90(5):446-60. PubMed ID: 25908509
[TBL] [Abstract][Full Text] [Related]
5. Advances in first-line treatment of chronic lymphocytic leukemia: current recommendations on management and first-line treatment by the German CLL Study Group (GCLLSG).
Cramer P; Langerbeins P; Eichhorst B; Hallek M
Eur J Haematol; 2016 Jan; 96(1):9-18. PubMed ID: 26332019
[TBL] [Abstract][Full Text] [Related]
6. Chronic lymphocytic leukemia: 2013 update on diagnosis, risk stratification and treatment.
Hallek M
Am J Hematol; 2013 Sep; 88(9):803-16. PubMed ID: 23720127
[TBL] [Abstract][Full Text] [Related]
7. Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia.
Robak T; Lech-Maranda E; Robak P
Expert Rev Anticancer Ther; 2010 Oct; 10(10):1529-43. PubMed ID: 20942624
[TBL] [Abstract][Full Text] [Related]
8. [Chronic lymphocytic leukemia].
Maurer C; Hallek M
Dtsch Med Wochenschr; 2013 Oct; 138(42):2153-66. PubMed ID: 24104591
[TBL] [Abstract][Full Text] [Related]
9. Evolving Strategies for the Treatment of Chronic Lymphocytic Leukemia in the Upfront Setting.
Bachow SH; Lamanna N
Curr Hematol Malig Rep; 2016 Feb; 11(1):61-70. PubMed ID: 26951237
[TBL] [Abstract][Full Text] [Related]
10. Initial therapy of chronic lymphocytic leukemia.
Eichhorst B; Cramer P; Hallek M
Semin Oncol; 2016 Apr; 43(2):241-50. PubMed ID: 27040702
[TBL] [Abstract][Full Text] [Related]
11. Comparison of real-world treatment patterns in chronic lymphocytic leukemia management before and after availability of ibrutinib in the province of British Columbia, Canada.
Huang SJ; Gerrie AS; Young S; Tucker T; Bruyere H; Hrynchak M; Galbraith P; Al Tourah AJ; Dueck G; Noble MC; Ramadan KM; Tsang P; Hardy E; Sehn L; Toze CL
Leuk Res; 2020 Apr; 91():106335. PubMed ID: 32114372
[TBL] [Abstract][Full Text] [Related]
12. Current Treatment of Chronic Lymphocytic Leukemia.
Jamroziak K; Puła B; Walewski J
Curr Treat Options Oncol; 2017 Jan; 18(1):5. PubMed ID: 28185174
[TBL] [Abstract][Full Text] [Related]
13. Chronic lymphocytic leukemia: current and emerging treatment approaches.
Kay NE; Rai KR; O'Brien S
Clin Adv Hematol Oncol; 2006 Nov; 4(11 Suppl 22):1-10; quiz 11-2. PubMed ID: 17143256
[TBL] [Abstract][Full Text] [Related]
14. Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment.
Hallek M
Am J Hematol; 2019 Nov; 94(11):1266-1287. PubMed ID: 31364186
[TBL] [Abstract][Full Text] [Related]
15. Immune recovery after fludarabine-cyclophosphamide-rituximab treatment in B-chronic lymphocytic leukemia: implication for maintenance immunotherapy.
Ysebaert L; Gross E; Kühlein E; Blanc A; Corre J; Fournié JJ; Laurent G; Quillet-Mary A
Leukemia; 2010 Jul; 24(7):1310-6. PubMed ID: 20463751
[TBL] [Abstract][Full Text] [Related]
16. [Chronic lymphocytic leukemia : treatment concepts in transition].
Eichhorst B; Hallek M
Internist (Berl); 2015 Apr; 56(4):374-80. PubMed ID: 25776793
[TBL] [Abstract][Full Text] [Related]
17. A network meta-analysis of progression free survival and overall survival in first-line treatment of chronic lymphocytic leukemia.
Ladyzynski P; Molik M; Foltynski P
Cancer Treat Rev; 2015 Feb; 41(2):77-93. PubMed ID: 25512118
[TBL] [Abstract][Full Text] [Related]
18. Fludarabine, cyclophosphamide, and multiple-dose rituximab as frontline therapy for chronic lymphocytic leukemia.
Short NJ; Keating MJ; Wierda WG; Faderl S; Ferrajoli A; Estrov Z; Smith SC; O'Brien SM
Cancer; 2015 Nov; 121(21):3869-76. PubMed ID: 26218678
[TBL] [Abstract][Full Text] [Related]
19. Modern concepts in the treatment of chronic lymphocytic leukemia.
Smolej L
Hematology; 2009 Oct; 14(5):249-54. PubMed ID: 19843378
[TBL] [Abstract][Full Text] [Related]
20. State-of-the-Art Treatment and Novel Agents in Chronic Lymphocytic Leukemia.
Cramer P; Hallek M; Eichhorst B
Oncol Res Treat; 2016; 39(1-2):25-32. PubMed ID: 26890007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]